TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AVLN

Avalyn Pharma Inc.

Healthcare · Biotechnology

28.40$ +1.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Avalyn Pharma Inc. (AVLN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -81 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow AVLN
Line item 2024 2025
-48 -81
0.0 0.0
2.5 3.3
1.4 2.6
0.1 0.3
– 10
0.1 100
-140 28
-48 -82

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?